US Patent Issued to Enveric Biosciences Canada on Sept. 30 for "Fused heterocyclic mescaline derivatives" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,408, issued on Sept. 30, was assigned to Enveric Biosciences Canada Inc. (Calgary, Canada).

"Fused heterocyclic mescaline derivatives" was invented by Peter J. Facchini (Calgary, Canada), Jillian M. Hagel (Calgary, Canada), Chang-Chun Ling (Calgary, Canada), Ye Cai (Edmonton, Canada), David James Press (Calgary, Canada), Glynnis Elizabeth Jensen (Calgary, Canada), Jessica Bik-Jing Lee (Calgary, Canada) and Kaveh Matinkhoo (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are novel fused heterocyclic mescaline derivative compounds, notably fused heterocyclic mescaline derivatives and pharmaceutical and recreational drug formu...